MCRB
Price
$9.08
Change
-$0.65 (-6.68%)
Updated
Apr 24 closing price
Capitalization
79.16M
12 days until earnings call
MTVA
Price
$0.85
Change
+$0.04 (+4.94%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
8.57M
Ad is loading...

MCRB vs MTVA

Header iconMCRB vs MTVA Comparison
Open Charts MCRB vs MTVABanner chart's image
Seres Therapeutics
Price$9.08
Change-$0.65 (-6.68%)
Volume$138.22K
Capitalization79.16M
MetaVia
Price$0.85
Change+$0.04 (+4.94%)
Volume$5.46K
Capitalization8.57M
MCRB vs MTVA Comparison Chart
Loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCRB vs. MTVA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a StrongBuy and MTVA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (MCRB: $9.08 vs. MTVA: $0.85)
Brand notoriety: MCRB and MTVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 190% vs. MTVA: 30%
Market capitalization -- MCRB: $79.16M vs. MTVA: $8.57M
MCRB [@Biotechnology] is valued at $79.16M. MTVA’s [@Biotechnology] market capitalization is $8.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 0 FA rating(s) are green whileMTVA’s FA Score has 1 green FA rating(s).

  • MCRB’s FA Score: 0 green, 5 red.
  • MTVA’s FA Score: 1 green, 4 red.
According to our system of comparison, MTVA is a better buy in the long-term than MCRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 4 TA indicator(s) are bullish while MTVA’s TA Score has 4 bullish TA indicator(s).

  • MCRB’s TA Score: 4 bullish, 4 bearish.
  • MTVA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MCRB is a better buy in the short-term than MTVA.

Price Growth

MCRB (@Biotechnology) experienced а +22.70% price change this week, while MTVA (@Biotechnology) price change was +15.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

MCRB is expected to report earnings on Aug 05, 2025.

MTVA is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCRB($79.2M) has a higher market cap than MTVA($8.57M). MCRB YTD gains are higher at: -45.367 vs. MTVA (-58.128). MTVA has higher annual earnings (EBITDA): -25.46M vs. MCRB (-120.3M). MTVA has less debt than MCRB: MTVA (154K) vs MCRB (91.6M). MCRB (0) and MTVA (0) have equivalent revenues.
MCRBMTVAMCRB / MTVA
Capitalization79.2M8.57M924%
EBITDA-120.3M-25.46M473%
Gain YTD-45.367-58.12878%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A21.7M-
Total Debt91.6M154K59,481%
FUNDAMENTALS RATINGS
MCRB vs MTVA: Fundamental Ratings
MCRB
MTVA
OUTLOOK RATING
1..100
2550
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
9297
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTVA's Valuation (22) in the null industry is somewhat better than the same rating for MCRB (57) in the Biotechnology industry. This means that MTVA’s stock grew somewhat faster than MCRB’s over the last 12 months.

MTVA's Profit vs Risk Rating (100) in the null industry is in the same range as MCRB (100) in the Biotechnology industry. This means that MTVA’s stock grew similarly to MCRB’s over the last 12 months.

MTVA's SMR Rating (96) in the null industry is in the same range as MCRB (99) in the Biotechnology industry. This means that MTVA’s stock grew similarly to MCRB’s over the last 12 months.

MCRB's Price Growth Rating (92) in the Biotechnology industry is in the same range as MTVA (97) in the null industry. This means that MCRB’s stock grew similarly to MTVA’s over the last 12 months.

MCRB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MTVA (100) in the null industry. This means that MCRB’s stock grew similarly to MTVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCRBMTVA
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBLLX9.89N/A
N/A
Allspring Large Cap Value Admin
JHDAX17.85N/A
N/A
JPMorgan Hedged Equity 2 A
FGIPX14.29N/A
N/A
Macquarie Growth and Income Instl
DGEFX12.66N/A
N/A
Destinations Equity Income I
LHCIX17.82N/A
N/A
Lord Abbett Health Care I

MCRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
-6.68%
ORMP - MCRB
42%
Loosely correlated
-0.43%
AXON - MCRB
38%
Loosely correlated
+2.39%
AMRN - MCRB
36%
Loosely correlated
+7.92%
ARRY - MCRB
34%
Loosely correlated
+5.31%
ALNY - MCRB
34%
Loosely correlated
+0.26%
More

MTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been loosely correlated with SPRB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if MTVA jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
+4.55%
SPRB - MTVA
66%
Loosely correlated
+5.27%
HOOK - MTVA
44%
Loosely correlated
+7.71%
PMVP - MTVA
35%
Loosely correlated
+0.93%
KPRX - MTVA
30%
Poorly correlated
+2.56%
MCRB - MTVA
29%
Poorly correlated
-6.68%
More